Navigation Links
GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
Date:10/29/2010

t attack and stroke.

It is currently estimated that Fabry disease affects approximately 5,000 to 10,000 people worldwide.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com

Amicus TherapeuticsAmicus Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases.  The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and CNS diseases.  Amicus' lead program is in Phase 3 for the treatment of Fabry disease.  For further information, please visit www.amicustherapeutics.com.Amicus Enquiries:Analyst/Investor and Media enquiries:

Jenene Thomas

(609) 662-5084GlaxoSmithKline Enquiries:UK Media enquiries:

David Mawdsley

(020) 8047 5502Claire Brough

(020) 8047 5502Stephen Rea

(020) 8047 5502Alexandra Harrison

(020) 8047 5502Jo Revill

(020) 8047 5502US Media enquiries:

Nancy Pekarek

(919) 483 2839Mary Anne Rhyne

(919) 483 2839Kevin Colgan

(919) 483 2839Sarah Alspach

(919) 483 2839European Analyst/Investor enquiries:

Sally Ferguson

(020) 8047 5543Gary Davies

(020) 8047 5503US Analyst/ Investor enquiries:

Tom Curry

(215) 751 5419Jen Hill Baxter

(215) 751 7002Amicus Forward-Looking Statements This press release contains, and the accompanying conference call will contain, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to preclinical and clinical d
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... Oxybutynin Hydrochloride Industry, 2009-2019 is a professional ... Chinese Oxybutynin Hydrochloride industry. The report firstly ... including its classification, application and manufacturing technology. ... top manufacturers of Oxybutynin Hydrochloride listing their ...
(Date:9/19/2014)... Sept. 19, 2014 /PRNewswire-iReach/ -- "United ... 2020″, provides key market data on ... market. The report provides value, in ... (in units) within market categories – ... Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, ...
(Date:9/19/2014)... -- Kiromic, LLC, a Lubbock bio-pharmaceutical ... the former chancellor of Texas Tech University, to its board ... 2014, after raising $1.2 billion for the university. ... the most successful chancellor in the history of Texas Tech ... investor, but also as our new vice chairman of the ...
Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
... Pharmaceuticals (Nasdaq: ENDP ) announced today that it has ... related to LecTec,s U.S. Patent Nos. 5,536,263 and 5,741,510. , ... payment for the exclusive license to these two patents for ... "We are pleased to add these patents to our IP ...
... CLEVELAND, Nov. 11 ChanTest, a leading provider of ... for drug discovery and development, today announced that Dr. ... to its board of directors. Dr. Mills is presently ... logistics, and biological specimens and data storage services for ...
Cached Medicine Technology:Endo Pharmaceuticals and LecTec Settle Patent Dispute 2Endo Pharmaceuticals and LecTec Settle Patent Dispute 3Endo Pharmaceuticals and LecTec Settle Patent Dispute 4Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation 2
(Date:9/20/2014)... Wisconsin (PRWEB) September 20, 2014 QueenBeeTickets.com ... the young star’s tour performances. She will visit many ... of February until the 16th of April. , ... Grande Honeymoon Tour tickets at QueenBeeTickets.com. , The star’s ... opportunity to see their favorite young singer in a ...
(Date:9/20/2014)... AZ (PRWEB) September 20, 2014 The ... Community College (MCC) is celebrating National Manufacturing Day by ... its enhanced machining, processing and additive manufacturing labs will ... Oct. 3, 2014 at MCC’s Southern and Dobson campus ... available in southeast Lot D. , The AzAMI at ...
(Date:9/20/2014)... 2014 MarijuanaDoctors.com recently returned to ... the PAIN Week conference that was held at ... in Las Vegas from September 2nd to September ... Week in the hopes of educating physicians in ... legitimate tool to treat chronic Pain, MarijuanaDoctors.com accomplished ...
(Date:9/19/2014)... 2014 Consistent premium price increases ... Vision Insurance industry in recent years; however, costs ... industry margins. From 2009 to 2014, industry revenue ... coverage for routine eye exams and other procedures, ... lens and refractive surgery. According to IBISWorld Industry ...
(Date:9/19/2014)... City, KS (PRWEB) September 19, 2014 ... is responding to families in regions of the Philippines being ... , More than 1,060 families evacuated to the nearest ... storm Fung-Wong brought heavy rain and gusty winds to portions ... Friday causing heavy flooding. Some homes filled with more than ...
Breaking Medicine News(10 mins):Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2
... risk, study finds , WEDNESDAY, Feb. 3 (HealthDay News) ... associated with increased loss of bone mineral density and ... premature death, researchers say. , "Our findings highlight the ... fracture risk," Dr. Sophie A. Jamal, of the University ...
... , CINCINNATI , Feb. 3 ... as the winningest in franchise history, with a first time trip to ... BREES ( PURDUE ) consistent and dependable blocking throughout the ... Orleans Saints offensive line was the first to be honored and named ...
... , SAN DIEGO , Feb. 3 ... named among the top 100 integrated health care networks in the nation ... analyst. Sharp was ranked No. 6 in the nation and No. 1 ... by Modern Healthcare , is regarded as the nation,s premier rating ...
... , , New York ,s Automobile Insurance System Is Currently ... Feb. 3 Fraud and abuse in New York ... million in 2009, constituting a "fraud tax" of $1,561 , ... Hartwig , an economist and president of the Insurance Information Institute ...
... linking obesity and DNA , WEDNESDAY, Feb. 3 (HealthDay News) ... European scientists report that a genetic variation seems to virtually ... variation in question robs people of about 30 genes and ... obese people, the researchers report. The same variation also may ...
... ... New Jersey , ... 3, 2010 -- IntertechPira is pleased to announce the dates and location for the 8th ... Newark, New Jersey on October 18 - 20, this event promises to provide attendees with ...
Cached Medicine News:Health News:Kidney Function May Be Tied to Bone Loss 2Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 2Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 3Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 4Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 5Health News:Sharp HealthCare Rated Top Health Care Network in California and No. 6 in the Nation 2Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 2Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 3Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 4Health News:Very Obese People May Be Missing Genes 2Health News:Dates Announced for IntertechPira's 8th Color Cosmetics Summit 2
... navigation system for ENT, cranial and ... zones preoperatively, critical zones visible during ... direct vision, one button freezes image, ... image. Microscope interface: tracks focal point ...
... The spinal system neon is a modular ... extends from occipitocervical via cervical to cervicothoracic ... can be used for the entire spinal ... connection used by the system also provides ...
...
...
Medicine Products: